Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Beauty Health (SKIN) Other Non Operating Income (2020 - 2026)

SkinHealth Systems has reported Other Non Operating Income over the past 6 years, most recently at $12.7 million for Q4 2025.

  • Quarterly Other Non Operating Income fell 62.22% to $12.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.5 million through Dec 2025, down 6.0% year-over-year, with the annual reading at $18.9 million for FY2025, 43.6% down from the prior year.
  • Other Non Operating Income was $12.7 million for Q4 2025 at SkinHealth Systems, up from $601000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $33.7 million in Q4 2024 and troughed at -$4.3 million in Q2 2021.
  • The 5-year median for Other Non Operating Income is $259000.0 (2022), against an average of $3.3 million.
  • Year-over-year, Other Non Operating Income tumbled 7791.07% in 2021 and then soared 12721.05% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $4.2 million in 2021, then plummeted by 96.45% to $150000.0 in 2022, then tumbled by 2068.0% to -$3.0 million in 2023, then surged by 1242.51% to $33.7 million in 2024, then plummeted by 62.22% to $12.7 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Other Non Operating Income are $12.7 million (Q4 2025), $601000.0 (Q3 2025), and $18.1 million (Q2 2025).